Pancreatic Cancer Research

ResearcherUniversity of Nebraska–LincolnActive in the last 2 years

Robert Powers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9948-6837; OpenAlex author ID A5016524389. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
50
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 11

  1. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  2. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  3. Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant-Antioxidant Balance. Co-author DOI 10.3390/cancers15092593↗
  4. Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies. Last author DOI 10.3390/biom12101391↗
  5. DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acs.jproteome.1c00233↗
  6. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts. Co-author DOI 10.1002/ijc.30904↗
  7. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2017.06.004↗
  8. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. Last author DOI 10.1021/acs.jproteome.7b00246↗
  9. Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer. Last author DOI 10.1021/bi401329a↗
  10. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Co-author DOI 10.1186/2049-3002-2-18↗
  11. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Co-author DOI 10.1073/pnas.1203339109↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nina V. Chaika · 7 shared papers, 2012–2024 · strength 0.50
  2. Pankaj Kumar Singh · 7 shared papers, 2012–2024 · strength 0.50
  3. Teklab Gebregiworgis · 6 shared papers, 2012–2024 · strength 0.45
  4. Kamiya Mehla · 6 shared papers, 2012–2024 · strength 0.43
  5. Surendra Kumar Shukla · 5 shared papers, 2014–2024 · strength 0.43
  6. Heidi E. Roth · 2 shared papers, 2021–2022 · strength 0.40
  7. Michael Anthony Hollingsworth · 4 shared papers, 2012–2024 · strength 0.35
  8. Scott E. Mulder · 3 shared papers, 2017–2024 · strength 0.34
  9. Divya Murthy · 3 shared papers, 2017–2024 · strength 0.32
  10. Aneesha Dasgupta · 3 shared papers, 2017–2024 · strength 0.32
  11. Ryan J. King · 3 shared papers, 2017–2024 · strength 0.32
  12. Paul M. Grandgenett · 3 shared papers, 2017–2024 · strength 0.32
  13. Kuldeep Singh Attri · 3 shared papers, 2017–2024 · strength 0.32
  14. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  15. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  16. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  17. Tuo Hu · 2 shared papers, 2024 · strength 0.28
  18. Chunbo He · 2 shared papers, 2024 · strength 0.28
  19. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  20. Sai Sundeep Kollala · 2 shared papers, 2024 · strength 0.28
  21. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  22. Ravi Kumar Thakur · 2 shared papers, 2024 · strength 0.28
  23. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28
  24. Amarnath (Amar) Natarajan · 2 shared papers, 2024 · strength 0.28
  25. Susanna Varkey Ulahannan · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.